Two Sigma Investments, LP Seelos Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $270,707 - $116 Million	-416,473 Reduced 85.0%	73,499 $76,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $264,086 - $481,569	-517,817 Reduced 51.38%	489,972 $333,000
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $203,779 - $414,837	-242,595 Reduced 19.4%	1,007,789 $844,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $430,945 - $645,063	271,035 Added 27.68%	1,250,384 $2.04 Million
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $1.39 Million - $2.38 Million	-823,792 Reduced 45.69%	979,349 $2.36 Million
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $4.76 Million - $11.4 Million	1,803,141 New	1,803,141 $4.76 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.